Trials / Completed
CompletedNCT03850327
BIO|CONCEPT.BIOMONITOR III
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Biotronik SE & Co. KG · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to confirm the safety and efficacy of the BIOMONITOR III system. Furthermore, the insertion procedure, the use and handling of the incision and insertion tools and the sensing quality of the BIOMONITOR III will be assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | BIOMONITOR III | Patients with ICM indication receive a third-generation implantable cardiac monitor |
Timeline
- Start date
- 2019-03-08
- Primary completion
- 2019-10-06
- Completion
- 2019-10-06
- First posted
- 2019-02-21
- Last updated
- 2021-05-27
Locations
7 sites across 1 country: Australia
Source: ClinicalTrials.gov record NCT03850327. Inclusion in this directory is not an endorsement.